Terms: = Breast cancer AND CAMTA1, ENSG00000171735, 23261, Q9Y6Y1, KIAA0833
6 results:
1. Clinicopathologic Characterization of Epithelioid Hemangioendothelioma in a Series of 62 Cases: A Proposal of Risk Stratification and Identification of a Synaptophysin-positive Aggressive Subset.
Shibayama T; Makise N; Motoi T; Mori T; Hiraoka N; Yonemori K; Watanabe SI; Esaki M; Morizane C; Okuma T; Kawai A; Ushiku T; Yatabe Y; Yoshida A
Am J Surg Pathol; 2021 May; 45(5):616-626. PubMed ID: 33729740
[TBL] [Abstract] [Full Text] [Related]
2. Case of epithelioid hemangioendothelioma occurring in the postradiation setting for breast cancer.
Hahn E; Dickson BC; Gupta AA; Nofech-Mozes S
Genes Chromosomes Cancer; 2021 Feb; 60(2):112-115. PubMed ID: 33125182
[TBL] [Abstract] [Full Text] [Related]
3. Long Noncoding RNA camta1 Promotes Proliferation and Mobility of the Human breast cancer Cell Line MDA-MB-231 via Targeting miR-20b.
Lu P; Gu Y; Li L; Wang F; Yang X; Yang Y
Oncol Res; 2018 May; 26(4):625-635. PubMed ID: 28550685
[TBL] [Abstract] [Full Text] [Related]
4. camta1 is a useful immunohistochemical marker for diagnosing epithelioid haemangioendothelioma.
Shibuya R; Matsuyama A; Shiba E; Harada H; Yabuki K; Hisaoka M
Histopathology; 2015 Dec; 67(6):827-35. PubMed ID: 25879300
[TBL] [Abstract] [Full Text] [Related]
5. camta1 immunostaining is not useful in differentiating epithelioid hemangioendothelioma from its potential mimickers.
Yusıflı Z; Kösemehmetoğlu K
Turk Patoloji Derg; 2014; 30(3):159-65. PubMed ID: 25110239
[TBL] [Abstract] [Full Text] [Related]
6. Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma.
Tanas MR; Sboner A; Oliveira AM; Erickson-Johnson MR; Hespelt J; Hanwright PJ; Flanagan J; Luo Y; Fenwick K; Natrajan R; Mitsopoulos C; Zvelebil M; Hoch BL; Weiss SW; Debiec-Rychter M; Sciot R; West RB; Lazar AJ; Ashworth A; Reis-Filho JS; Lord CJ; Gerstein MB; Rubin MA; Rubin BP
Sci Transl Med; 2011 Aug; 3(98):98ra82. PubMed ID: 21885404
[TBL] [Abstract] [Full Text] [Related]
